n.ramos

TL2 · Bologna

Contributes reviews on supplier material. Based in Bologna.

Joined 30 December 2024 · last posted 6d

92 posts, newest first. Showing up to 150.

Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #55 · Compounds › Secretagogues & GH axis · 22 Jul 2026 · 5 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
Journal club: what we got wrong in an earlier session Replied, post #90 · Evidence › Journal club · 16 Jul 2026 · 21 likes Post #88 and I disagree about the size of the effect, not about the direction. A conflict-of-interest statement is worth reading aloud and is worth very little as a…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #100 · Sourcing › Vendor reports · 12 Jul 2026 · 2 likes Fair, and the limits you put on it are the part I will remember.
An 18-month record including the parts that went badly Replied, post #66 · Outcomes › Progress reports · 11 Jul 2026 · 26 likes Two people in this thread mean different things by 18-month record and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
About the Impurities & related substances category Replied, post #9 · Analytics › Impurities & related substances · 4 Jul 2026 · 7 likes Building on post #6 rather than restating it. Peptide impurities that differ by a single residue are the hardest to resolve and the most likely to be biologically…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 3 Jul 2026 · 6 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Cagrilintide alone is well covered in the tag pages, and the older discussions are…
Revisiting: How this community labels and discusses unrefereed work Replied, post #6 · Evidence › Preprints · 22 Jun 2026 · 23 likes Post #5 is the version of this I will quote in future. One addition. The honest position on most preprints in this field is that they are interesting and provisional,…
Naming conventions for research peptides and the confusion they cause Replied, post #16 · Compounds › Other compounds · 16 Jun 2026 · 7 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. This subcategory exists because some people will research…
Second pass at: Metformin co-administration and additive GI effects Replied, post #124 · Practice › Interactions · 12 Jun 2026 · 12 likes Agreed on Metformin co-administration, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #47 · Analytics › Method validation · 8 Jun 2026 · 21 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #41 · Sourcing › Red flags · 4 Jun 2026 · 7 likes I have no financial interest in anything named in this thread and I want to say so before I comment on certificate whose chromatogram axes, because it is the sort of…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #44 · Compounds › Semaglutide · 30 May 2026 · 0 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #26 · Pharmacology › Formulation chemistry · 26 May 2026 · 1 like Solubility limits would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Constipation management, with a dietitian's contribution Replied, post #69 · Practice › Side effects · 23 May 2026 · 3 likes Post #66 is the version of this I will quote in future. One addition. Where I have landed on constipation management, having got it wrong once in public: the direction…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #22 · Evidence › Trials · 11 May 2026 · 0 likes Worth separating two things that post #20 runs together. Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen after seeing…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #16 · Analytics › Home & field testing · 7 May 2026 · 18 likes Colorimetric and lateral-flow methods generally respond to a class of chemistry rather than to a specific molecule. They can often distinguish something from nothing…
[2026 update] Thyroid function tests during substantial weight change Replied, post #59 · Clinical › Bloodwork · 6 May 2026 · 12 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. Worth saying I have only my own numbers here, and n…
Blind submission and why it changes minds — the long version Replied, post #52 · Sourcing › Independent verification · 2 May 2026 · 0 likes What I would tell a new member reading about Blind submission for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #89 · Analytics › Mass spectrometry · 17 Apr 2026 · 1 like Post #86 answers the question as asked. The question underneath it is different. Where I have landed on Charge states, having got it wrong once in public: the direction…
Coming back to: Time to steady state after a dose increase Replied, post #34 · Pharmacology › Pharmacokinetics · 17 Apr 2026 · 10 likes On post #30 — agreed on the reasoning, with one qualification. Between-person variability in exposure is substantial and is the reason two people on the same dose can…
Grapefruit: why this class is not the class that cares Replied, post #124 · Practice › Interactions · 5 Apr 2026 · 26 likes Post #121 describes the usual case. This is about the unusual one. Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class:…
Second pass at: Submitting a sample: the process end to end Replied, post #17 · Sourcing › Independent verification · 30 Mar 2026 · 9 likes Whatever the answer on Submitting a sample turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #56 · Start Here › Welcome · 21 Mar 2026 · 23 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #45 · Research Methods › Statistics · 4 Mar 2026 · 5 likes Building on post #42 rather than restating it. On Measurement error in home scales, I would rather understate and be corrected upward than overstate and be quoted. That…
Interpreting a result that disagrees with the supplier's certificate Replied, post #146 · Sourcing › Independent verification · 3 Mar 2026 · 0 likes Post #142 put the caveat in the right place and I want to underline it. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #96 · Evidence › Study critique · 28 Feb 2026 · 3 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. That holds…
Storing lyophilised material long term: what governs the shelf life Replied, post #81 · Practice › Storage & stability · 25 Feb 2026 · 1 like Agreed on all of that, and I have nothing to add to it.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #129 · Analytics › COA interpretation · 10 Feb 2026 · 7 likes Narrowing post #126, because the general version has more than one answer. Asking for the batch record rather than the certificate is a reasonable request and the…
Dead volume across syringe and needle combinations Replied, post #62 · Devices › Syringes & needles · 28 Jan 2026 · 8 likes Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a viscous preparation and pointless for an aqueous one. One case, stated…
Adolescents: a distinct evidence base — one year on Replied, post #57 · Clinical › Special populations · 24 Jan 2026 · 19 likes Post #53 describes the usual case. This is about the unusual one. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #6 · Compounds › Repair & healing peptides · 21 Jan 2026 · 0 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #9 · Practice › Administration · 15 Jan 2026 · 6 likes An honest declaration on Pinch: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #6 · Pharmacology › Pharmacokinetics · 1 Jan 2026 · 0 likes Washout has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Journal club: PIONEER 6 as a safety trial Replied, post #12 · Evidence › Journal club · 26 Dec 2025 · 24 likes On PIONEER 6: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #34 · Compounds › Retatrutide · 26 Dec 2025 · 5 likes Everything in post #32 holds. The case it does not cover is the one I have. On identity confirmation more generally: for a compound with no widely available reference…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #23 · Practice › Side effects · 9 Dec 2025 · 1 like Post #20 describes the usual case. This is about the unusual one. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #60 · Compounds › Semaglutide · 2 Dec 2025 · 4 likes Post #58 and I disagree about the size of the effect, not about the direction. Cardiovascular data in people without diabetes is the specific contribution of SELECT,…
Reading an interaction checker output critically Replied, post #41 · Practice › Interactions · 12 Nov 2025 · 5 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #76 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes The arithmetic in post #75 is right; the assumption feeding it is the part to check. Heart rate rises modestly across this class, tirzepatide included. It is…
What a confidence interval means, from scratch — the long version Replied, post #9 · Research Methods › Statistics · 22 Oct 2025 · 0 likes Source for the confidence interval figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #7 · Compounds › Oral incretins · 16 Oct 2025 · 0 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #98 · Lounge › Off topic · 15 Oct 2025 · 0 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. If that is already…
Pinch or no pinch, and how needle length changes the answer Replied, post #99 · Practice › Administration · 8 Oct 2025 · 0 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first. The…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #56 · Sourcing › Vendor reports · 14 Sep 2025 · 5 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
Coming back to: What published stability data actually covers, and what it does not Replied, post #140 · Practice › Storage & stability · 14 Sep 2025 · 0 likes Post #137 is the version of this I will quote in future. One addition. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
A preprint whose numbers changed substantially at publication Replied, post #52 · Evidence › Preprints · 14 Sep 2025 · 14 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
When to stop reading forums, including this one Replied, post #21 · Wellbeing › Mental health · 2 Sep 2025 · 14 likes A change that came on with an escalation and settled is a different observation from one that has persisted for months. A partial answer, offered because a partial…
An emergency department visit, described afterwards Replied, post #57 · Safety › Adverse events · 22 Aug 2025 · 5 likes This follows post #55 rather than contradicting it. Emergency department visit is a good example of a question where the honest answer is boring and the interesting…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #110 · Compounds › Tirzepatide · 21 Aug 2025 · 24 likes Everything in post #108 holds. The case it does not cover is the one I have. On the mechanism question specifically: the honest position is that GIP agonism plausibly…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #47 · Compounds › Retatrutide · 13 Aug 2025 · 1 like TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #7 · Evidence › Journal club · 9 Aug 2025 · 6 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
A request that was declined, and the reasoning — a second dataset Replied, post #7 · Documentation › Wiki requests · 5 Aug 2025 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Say what would make the page wrong. A page whose failure conditions are stated is much easier to review…
EU-wide position versus national implementation Replied, post #23 · Regional › European Union · 5 Aug 2025 · 0 likes Everything in post #20 holds. The case it does not cover is the one I have. The most useful post in this subcategory is a link to the current national page in its own…
When a preprint is the best available evidence and we say so Replied, post #19 · Evidence › Preprints · 3 Aug 2025 · 16 likes I keep a log for preprint specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
"Should I double up?" — answered once, at length, calmly Replied, post #9 · Practice › Administration · 29 Jul 2025 · 16 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Journal club: SURMOUNT-1, read without the press release Replied, post #156 · Evidence › Journal club · 11 Jul 2025 · 29 likes Before the thread moves on from SURMOUNT-1 — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2025 · 16 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #23 · Data & Tools › Datasets · 3 Jul 2025 · 0 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #121 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 1 like Post #119 is right about the mechanism and I think understates the practical bit. Is synergy the right word for the combination data? A phase 2 trial cannot establish…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 1 like Worth separating two things that post #83 runs together. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage,…
Comparing my trajectory with the trial curves, carefully Replied, post #11 · Outcomes › Progress reports · 5 Jun 2025 · 0 likes Post #9 describes the usual case. This is about the unusual one. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and…
Coming back to: Why quantitation is the hard part, not detection Replied, post #22 · Analytics › Home & field testing · 2 Jun 2025 · 6 likes Something worth flagging about quantitation: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
Anxiety in the first weeks: drug, situation, or both Replied, post #87 · Wellbeing › Mental health · 12 May 2025 · 8 likes Anxiety has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
A certificate with no method stated: what can you conclude? Replied, post #47 · Analytics › COA interpretation · 8 Apr 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #79 · Devices › Cold chain · 4 Apr 2025 · 0 likes Agreed on all of that, and I have nothing to add to it.
Why cagrilintide alone is discussed so much less than in combination Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 19 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. Research-use-only cagrilintide is not approved for human use and the published…
Why cagrilintide alone is discussed so much less than in combination Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 2 likes The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2 established that the combination does something; the size of it in…
Preservatives: function, testing, and limits Replied, post #26 · Pharmacology › Formulation chemistry · 31 Mar 2025 · 7 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
Assessing a warm arrival: the decision process Replied, post #17 · Sourcing › Logistics · 22 Mar 2025 · 3 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
Counter-ion form: the field almost nobody reports — one year on Replied, post #87 · Analytics › COA interpretation · 16 Mar 2025 · 23 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
Charge states for a 4 kDa peptide, worked through Replied, post #110 · Analytics › Mass spectrometry · 15 Mar 2025 · 24 likes Confirming post #107 from a second method, which matters more than confirming it from a second person. Quantitation by MS: most quantitation is done by LC-UV detection…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #2 · Evidence › Journal club · 12 Mar 2025 · 2 likes The opening post and I disagree about the size of the effect, not about the direction. I would call the community position on retatrutide phase 2 obesity paper likely…
Counter-ion form: the field almost nobody reports — one year on Replied, post #62 · Analytics › COA interpretation · 9 Mar 2025 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
UK access routes, dated and sourced Started this topic · Regional › UK & Ireland · 15 Feb 2025 · 52 likes UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because…
Canadian access and provincial variation Replied, post #41 · Regional › North America · 1 Feb 2025 · 0 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
What a well-designed human trial of a secretagogue would look like Replied, post #3 · marked as the solution · Compounds › Secretagogues & GH axis · 17 Jan 2025 · 7 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
A page that has drifted out of date and needs a maintainer Replied, post #48 · Documentation › Wiki requests · 6 Jan 2025 · 7 likes Post #45 put the caveat in the right place and I want to underline it. Documents that are mostly a worked example age better than documents that are mostly a summary,…
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #18 · Practice › Dosing & titration · 19 Dec 2024 · 0 likes Worth separating two things that post #14 runs together. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #12 · Evidence › Journal club · 11 Dec 2024 · 7 likes On post #10 — agreed on the reasoning, with one qualification. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded…
Transit times by route, from a logged dataset — the long version Replied, post #37 · Sourcing › Logistics · 9 Dec 2024 · 10 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #111 · Practice › Dosing & titration · 24 Nov 2024 · 32 likes Post #109 and I disagree about the size of the effect, not about the direction. Concentration and dose get conflated constantly in this subcategory. Changing how much…
When "no data" is the complete and final answer Replied, post #20 · Compounds › Other compounds · 13 Nov 2024 · 14 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #6 · Practice › Reconstitution · 5 Nov 2024 · 17 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #89 · Clinical › Prescriber conversations · 31 Oct 2024 · 30 likes Post #88 answers the question as asked. The question underneath it is different. Bringing a record of symptoms with dates and severities makes an assessment materially…
Revisiting: Moderation log format change Replied, post #2 · Meta › Announcements · 19 Oct 2024 · 11 likes Marking my place. If it changes for me I will come back and say so.
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #8 · Compounds › Other compounds · 16 Oct 2024 · 27 likes Building on post #6 rather than restating it. The question underneath melanocortin agonists is usually "how would I tell?" rather than "what is true?", and that one has…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #16 · Clinical › Comorbidities · 10 Oct 2024 · 15 likes Second-hand on Hypertension improvement, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Requesting a page: what makes a good request — what changed since Replied, post #30 · Documentation › Wiki requests · 10 Oct 2024 · 27 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
Coming back to: Purity assay versus content assay: two different numbers Replied, post #13 · Analytics › COA interpretation · 8 Aug 2024 · 28 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #8 · Analytics › COA interpretation · 18 Jul 2024 · 0 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #7 · Compounds › Retatrutide · 15 Jul 2024 · 2 likes The useful distinction on Retatrutide dose escalation is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #5 · Practice › Administration · 7 Jul 2024 · 0 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went. The confident version of…